Growth hormone therapy increased myocyte fractional shortening (14.1% vs 11.1%, P<0.05) and peak systolic calcium (647 vs 509 nmol/L, P<0.05) in rats with postinfarction heart failure.
Does recombinant human growth hormone improve contractile reserve and intracellular calcium transients in myocytes from rats with postinfarction heart failure?
Growth hormone therapy enhances calcium-dependent contractile reserve and restores systolic intracellular calcium augmentation in myocytes from rats with postinfarction heart failure.
Absolute Event Rate: 14.1% vs 11.1%
p-value: p=<0.05
BACKGROUND: Recombinant human growth hormone (GH) improves in vivo cardiac function in rats with postinfarction heart failure (MI). We examined the effects of growth hormone (14 days of 3.5 mg. kg-1. d-1 begun 4 weeks after MI) on contractile reserve in left ventricular myocytes from rats with chronic postinfarction heart failure. METHODS AND RESULTS: Cell shortening and Ca2+i were measured with the indicator fluo 3 in myocytes from MI, MI+GH, control, and normal animals treated with GH (C+GH) under stimulation at 0.5 Hz at 37 degrees C. Cell length was similar in MI and MI+GH rats (150+/-5 and 157+/-5 microm) and was greater in these groups than in the control and C+GH groups (140+/-4 and 139+/-4 microm, P<0.05). At baseline perfusate calcium of 1.2 mmol/L, myocyte fractional shortening and Ca2+i transients were similar among the 4 groups. We then assessed contractile reserve by measuring the increase in myocyte fractional shortening in the presence of high-perfusate calcium of 3.5 mmol/L. In the control and C+GH groups, myocyte fractional shortening and peak systolic Ca2+i were similarly increased in the presence of high-perfusate calcium. In the presence of high-perfusate calcium, both myocyte fractional shortening and peak systolic Ca2+i were depressed in the MI compared with the control groups. In contrast, myocyte fractional shortening (14.1+/-.9% versus 11.1+/-.9%, P<0.05) and peak systolic Ca2+i (647+/-43 versus 509+/-37 nmol/L, P<0.05) were significantly higher in MI+GH than in MI rats and were comparable to controls. Left ventricular myocyte expression of sarcoplasmic reticulum Ca2+ ATPase 2 (SERCA-2) and left ventricular SERCA-2 protein levels were increased in MI+GH compared with MI rats. CONCLUSIONS: Calcium-dependent contractile reserve is depressed in myocytes from rats with postinfarction heart failure. Long-term growth hormone therapy increases contractile reserve by restoring normal augmentation of systolic Ca2+i in myocytes from rats with postinfarction heart failure.
Tajima et al. (Tue,) conducted a other in Postinfarction heart failure. Recombinant human growth hormone vs. No growth hormone (MI control) was evaluated on Myocyte fractional shortening in the presence of high-perfusate calcium (p=<0.05). Growth hormone therapy increased myocyte fractional shortening (14.1% vs 11.1%, P<0.05) and peak systolic calcium (647 vs 509 nmol/L, P<0.05) in rats with postinfarction heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: